{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1045.41","meta":{"source":"https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1045.41/expansion"},"url":"http://vsac.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.41","version":"eCQM Update 2020-05-07","name":"GlycoproteinIIb/IIIaInhibitors","title":"Glycoprotein IIb/IIIa Inhibitors","status":"active","date":"2017-07-25","description":"(Clinical Focus: This value set contains concepts that represent codes that identify glycoprotein Iib/IIIa inhibitors.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on a glycoprotein Iib/IIIa inhibitor. ),(Inclusion Criteria: Includes only relevant concepts associated with a glycoprotein Iib/IIIa inhibitor. These are RxNorm codes.),(Exclusion Criteria: No exclusions.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"2020-01","concept":[{"code":"1736470","display":"10 ML eptifibatide 2 MG/ML Injection"},{"code":"1736477","display":"100 ML eptifibatide 2 MG/ML Injection"},{"code":"1737466","display":"100 ML tirofiban 0.05 MG/ML Injection"},{"code":"1737471","display":"250 ML tirofiban 0.05 MG/ML Injection"},{"code":"1813035","display":"15 ML tirofiban 0.25 MG/ML Injection"},{"code":"200349","display":"100 ML eptifibatide 0.75 MG/ML Injection"},{"code":"241162","display":"5 ML abciximab 2 MG/ML Injection"}]}]}}